Bank Pictet & Cie (Europe)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.7M Buy
164,654
+70,753
+75% +$7.6M 0.38% 57
2025
Q1
$9.47M Buy
93,901
+20,805
+28% +$2.1M 0.23% 66
2024
Q4
$6.53M Buy
73,096
+21,173
+41% +$1.89M 0.14% 78
2024
Q3
$4.35M Sell
51,923
-27,416
-35% -$2.3M 0.1% 78
2024
Q2
$6.11M Buy
79,339
+23,486
+42% +$1.81M 0.15% 71
2024
Q1
$3.83M Sell
55,853
-1,846
-3% -$126K 0.1% 81
2023
Q4
$3.34M Sell
57,699
-95,504
-62% -$5.52M 0.1% 96
2023
Q3
$8.09M Buy
153,203
+131,853
+618% +$6.96M 0.28% 65
2023
Q2
$1.15M Buy
21,350
+2,072
+11% +$112K 0.04% 132
2023
Q1
$964K Buy
19,278
+563
+3% +$28.2K 0.04% 108
2022
Q4
$866K Buy
18,715
+200
+1% +$9.25K 0.04% 106
2022
Q3
$717K Sell
18,515
-8,734
-32% -$338K 0.04% 111
2022
Q2
$1.02M Sell
27,249
-10,545
-28% -$393K 0.05% 98
2022
Q1
$1.67M Sell
37,794
-543
-1% -$24.1K 0.06% 91
2021
Q4
$1.63M Sell
38,337
-77,100
-67% -$3.28M 0.06% 92
2021
Q3
$5.01M Sell
115,437
-239,695
-67% -$10.4M 0.19% 69
2021
Q2
$15.2M Sell
355,132
-310,329
-47% -$13.3M 0.53% 43
2021
Q1
$25.7M Buy
665,461
+31,473
+5% +$1.22M 1.03% 31
2020
Q4
$22.8M Buy
633,988
+620,800
+4,707% +$22.3M 1.12% 32
2020
Q3
$504K Sell
13,188
-6,730
-34% -$257K 0.03% 96
2020
Q2
$699K Buy
19,918
+2,987
+18% +$105K 0.05% 82
2020
Q1
$552K Buy
16,931
+164
+1% +$5.35K 0.05% 87
2019
Q4
$758K Sell
16,767
-3,010
-15% -$136K 0.11% 85
2019
Q3
$805K Sell
19,777
-370
-2% -$15.1K 0.14% 80
2019
Q2
$866K Buy
20,147
+14,177
+237% +$609K 0.15% 74
2019
Q1
$229K Sell
5,970
-9,370
-61% -$359K 0.04% 144
2018
Q4
$542K Buy
15,340
+3,170
+26% +$112K 0.11% 74
2018
Q3
$469K Buy
+12,170
New +$469K 0.07% 131